Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells
about
Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of ActionBroad targeting of angiogenesis for cancer prevention and therapyA Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer CellsEvaluation and selection of candidate reference genes for normalization of quantitative RT-PCR in Withania somnifera (L.) DunalEffect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV/Neu mice.Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives.WITHAFERIN A INDUCES APOPTOSIS IN RAT C6 GLIOMA CELLS THROUGH REGULATING NF-KB NUCLEAR TRANSLOCATION AND ACTIVATION OF CASPASE CASCADE.Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.Molecular insights into cancer therapeutic effects of the dietary medicinal phytochemical withaferin A.Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammationVimentin filament controls integrin α5β1-mediated cell adhesion by binding to integrin through its Ser38 residue.Interactome analysis of transforming growth factor-β-activated kinase 1 in Helicobacter pylori-infected cells revealed novel regulators tripartite motif 28 and CDC37.Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
P2860
Q26766956-FBE6B634-ACBC-4294-9EB3-AD43A70D8EF1Q27002903-D045EB4B-6BCB-4057-A3B1-5FCF5358234EQ33755446-C8836285-436D-480D-AA2C-5632C5164EF0Q35175720-6FC13699-5BA1-4996-BD9D-2E3AA0B916EBQ35282975-7DF92EE5-902C-4474-8356-592BBBEBA344Q35595569-CCF8E64D-6B14-4EEA-9AD8-848CCB87743BQ38701553-E8AF9806-F2F1-48F2-82D0-7EC5095BAE92Q38764079-B35ED616-778D-49D4-A4D7-1ADFFB3791ACQ39120175-E5231AFD-9424-43DE-B0DA-86AF9F1074CFQ41093581-0B7F838D-CF6D-416D-81C8-1BEB470A8E1FQ41996902-ED530564-EF7D-451B-B8B1-7A2DC5D680FBQ48464466-364E0843-DD95-456A-B53E-18ED51045C56Q52340906-AFD8DA98-2C13-4915-A7D4-66F17EFEF3DCQ57243238-E8A9009D-23AC-46A6-A414-3BD192AAA0A2
P2860
Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacological levels of With ...... e negative breast cancer cells
@en
Pharmacological levels of Withaferin A
@nl
type
label
Pharmacological levels of With ...... e negative breast cancer cells
@en
Pharmacological levels of Withaferin A
@nl
prefLabel
Pharmacological levels of With ...... e negative breast cancer cells
@en
Pharmacological levels of Withaferin A
@nl
P2093
P2860
P50
P1433
P1476
Pharmacological levels of With ...... e negative breast cancer cells
@en
P2093
Dariusz Ratman
Erik Fransen
Karen Heyninck
Katarzyna Szarc vel Szic
Marc Bracke
P2860
P304
P356
10.1371/JOURNAL.PONE.0087850
P407
P50
P577
2014-02-03T00:00:00Z